search
Back to results

A Cluster-randomised Trial of Interventions to Improve Antimalarial Prescribing With Malaria Tests (TACT)

Primary Purpose

Malaria

Status
Completed
Phase
Not Applicable
Locations
Tanzania
Study Type
Interventional
Intervention
Control
HW
HWC
Sponsored by
London School of Hygiene and Tropical Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Malaria focused on measuring malaria, rdt, fever, treatment

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Health Facility Inclusion criteria:

  • Located in lowland Muheza, adjoining wards of Handeni, or any area of Moshi Rural Districts
  • Health facilities that are registered with the District Health Authority
  • Receives Government supplies of ALu and qualifies for RDT supply
  • Agrees to exclusive use of RDT for routine diagnosis of first consultations for possible malaria
  • Accessible by 4-wd vehicle throughout the year.
  • Availability of data on proportion of consultations diagnosed with malaria in 2008 (or earliest available year)

Health Facility Exclusion:

  • Presence of other research in the immediate area where study procedures could bias outcomes in either study.
  • Fewer than 500 cases per year were reported in 2005 or 2006.

Patient Inclusion:

  • All patients with non-severe illness in first consultations.
  • Patient Exclusion
  • Patients who have been referred to the next level of care
  • Patient refuses consent to exit survey
  • Follow-up consultations

Sites / Locations

  • Joint Malaria Programme

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Control

HW

HWC

Arm Description

Prescribing staff in control facilities will receive the standard package of RDT training that is being provided by NMCP in Tanzania

Prescribing staff in the intervention facilities will receive the same package of nationally-approved training in RDT use as will be provided to prescribers in control facilities. Following this, prescribers in the intervention facilities will be invited to participate in 3 small group training modules delivered in an interactive style lasting approximately 11/2 hours, with one session repeated between the 6th and 7th month of the trial.

The health worker-community arm will receive the same intervention as the health workers arm but with the addition of an intervention aimed at patients. This will consist of community sensitisation, clinic posters and providing a leaflet to each RDT-tested patient or caretaker giving details of the test and the corresponding treatment provided.

Outcomes

Primary Outcome Measures

The proportion of patients with a non-severe non-malarial illness prescribed a recommended antimalarial drug in a new consultation.

Secondary Outcome Measures

Full Information

First Posted
January 28, 2011
Last Updated
November 18, 2014
Sponsor
London School of Hygiene and Tropical Medicine
Collaborators
Kilimanjaro Christian Medical Centre, Tanzania, Ministry of Health, Tanzania
search

1. Study Identification

Unique Protocol Identification Number
NCT01292707
Brief Title
A Cluster-randomised Trial of Interventions to Improve Antimalarial Prescribing With Malaria Tests
Acronym
TACT
Official Title
A Cluster-randomised Trial of Health Worker and Community Interventions to Improve Adherence to National Guidelines for the Use of ACTs in Tanzania
Study Type
Interventional

2. Study Status

Record Verification Date
November 2014
Overall Recruitment Status
Completed
Study Start Date
February 2011 (undefined)
Primary Completion Date
February 2012 (Actual)
Study Completion Date
April 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
London School of Hygiene and Tropical Medicine
Collaborators
Kilimanjaro Christian Medical Centre, Tanzania, Ministry of Health, Tanzania

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Background. Overdiagnosis of malaria is widespread in health facilities throughout Africa, a situation that is unsustainable given the relatively high cost of artemisinin combination therapy (ACTs) compared to older antimalarials. In addition it often denies patients treatment for their actual illness and generates unreliable data for health planners. For these reasons the National Malaria Control Programme introduced revised guidelines for malaria diagnosis and treatment in 2006 restricting the recommendation for antimalarial treatment in patients over the age of 5 years to those with a positive blood slide or malaria rapid diagnostic tests (RDTs) result. To support this, RDTs will be introduced into primary care health facilities in Tanzania starting in 2009. The high accuracy of current rapid diagnostic tests (RDTs) provides the potential for a cost-effective solution to the problem of malaria overdiagnosis. However, RDTs with revised guidelines to restrict malaria diagnoses to RDT-positive patients have been unsuccessful unless accompanied by unsustainable levels of supervision and training. Primary objective. To conduct a trial of interventions directed at prescribers or prescribers and communities compared to control groups to improve adherence to national guidelines for prescription of antimalarial treatment when supported by RDTs in primary health care facilities in NE Tanzania. Methods All 60 participating health facilities will receive RDTs and basic training in their use and a copy of current NMCP/MOH guidelines for each prescribing staff member. A health worker intervention arm will, in addition, receive workplace-based interactive training and messages from senior staff A health worker-community arm will receive the same training as the health worker arm and in addition leaflets will be provided to RDT-tested patients providing information on the test and the treatment given. All training materials will be approved by NMCP in Tanzania as being consistent with current national guidelines but with the addition that prescribers will be asked to follow RDT results in prescribing for patients of any age This policy is in line with the most recent revision to WHO guidelines and is supported by NMCP in Tanzania. Study outcomes will be recorded through a 40% (2 days per week) exit survey of patients. Anthropological and economics studies will assess the costs and acceptability of interventions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malaria
Keywords
malaria, rdt, fever, treatment

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1152 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
Active Comparator
Arm Description
Prescribing staff in control facilities will receive the standard package of RDT training that is being provided by NMCP in Tanzania
Arm Title
HW
Arm Type
Active Comparator
Arm Description
Prescribing staff in the intervention facilities will receive the same package of nationally-approved training in RDT use as will be provided to prescribers in control facilities. Following this, prescribers in the intervention facilities will be invited to participate in 3 small group training modules delivered in an interactive style lasting approximately 11/2 hours, with one session repeated between the 6th and 7th month of the trial.
Arm Title
HWC
Arm Type
Active Comparator
Arm Description
The health worker-community arm will receive the same intervention as the health workers arm but with the addition of an intervention aimed at patients. This will consist of community sensitisation, clinic posters and providing a leaflet to each RDT-tested patient or caretaker giving details of the test and the corresponding treatment provided.
Intervention Type
Behavioral
Intervention Name(s)
Control
Intervention Description
Standard national training
Intervention Type
Behavioral
Intervention Name(s)
HW
Intervention Description
Prescribing staff in the intervention facilities will receive the same package of nationally-approved training in RDT use as will be provided to prescribers in control facilities. Following this, prescribers in the intervention facilities will be invited to participate in 3 small group training modules delivered in an interactive style lasting approximately 11/2 hours, with one session repeated between the 6th and 7th month of the trial
Intervention Type
Behavioral
Intervention Name(s)
HWC
Intervention Description
The health worker-community arm will receive the same intervention as the health workers arm but with the addition of an intervention aimed at patients. This will consist of community sensitisation, clinic posters and providing a leaflet to each RDT-tested patient or caretaker giving details of the test and the corresponding treatment provided.
Primary Outcome Measure Information:
Title
The proportion of patients with a non-severe non-malarial illness prescribed a recommended antimalarial drug in a new consultation.
Time Frame
1year

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Health Facility Inclusion criteria: Located in lowland Muheza, adjoining wards of Handeni, or any area of Moshi Rural Districts Health facilities that are registered with the District Health Authority Receives Government supplies of ALu and qualifies for RDT supply Agrees to exclusive use of RDT for routine diagnosis of first consultations for possible malaria Accessible by 4-wd vehicle throughout the year. Availability of data on proportion of consultations diagnosed with malaria in 2008 (or earliest available year) Health Facility Exclusion: Presence of other research in the immediate area where study procedures could bias outcomes in either study. Fewer than 500 cases per year were reported in 2005 or 2006. Patient Inclusion: All patients with non-severe illness in first consultations. Patient Exclusion Patients who have been referred to the next level of care Patient refuses consent to exit survey Follow-up consultations
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hugh Reyburn, MD
Organizational Affiliation
London School of Hygiene and Tropical Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Joint Malaria Programme
City
Moshi
State/Province
Kilimanjaro
Country
Tanzania

12. IPD Sharing Statement

Citations:
PubMed Identifier
26842751
Citation
Leurent B, Reyburn H, Muro F, Mbakilwa H, Schellenberg D. Monitoring patient care through health facility exit interviews: an assessment of the Hawthorne effect in a trial of adherence to malaria treatment guidelines in Tanzania. BMC Infect Dis. 2016 Feb 3;16:59. doi: 10.1186/s12879-016-1362-0.
Results Reference
derived
PubMed Identifier
25980737
Citation
Cundill B, Mbakilwa H, Chandler CI, Mtove G, Mtei F, Willetts A, Foster E, Muro F, Mwinyishehe R, Mandike R, Olomi R, Whitty CJ, Reyburn H. Prescriber and patient-oriented behavioural interventions to improve use of malaria rapid diagnostic tests in Tanzania: facility-based cluster randomised trial. BMC Med. 2015 May 15;13:118. doi: 10.1186/s12916-015-0346-z.
Results Reference
derived
PubMed Identifier
24969367
Citation
Chandler CI, Meta J, Ponzo C, Nasuwa F, Kessy J, Mbakilwa H, Haaland A, Reyburn H. The development of effective behaviour change interventions to support the use of malaria rapid diagnostic tests by Tanzanian clinicians. Implement Sci. 2014 Jun 26;9:83. doi: 10.1186/1748-5908-9-83.
Results Reference
derived

Learn more about this trial

A Cluster-randomised Trial of Interventions to Improve Antimalarial Prescribing With Malaria Tests

We'll reach out to this number within 24 hrs